PURPOSE: The serotonin system is undoubtedly involved in the pathogenesis of major depressive disorder (MDD). More specifically the serotonin transporter (SERT) serves as a major target for antidepressant drugs. There are conflicting results about SERT availability in depressed patients versus healthy controls. We aimed to measure SERT availability and study the effects of age, gender and season of scanning in MDD patients in comparison to healthy controls. METHODS: We included 49 depressed outpatients (mean+/-SD 42.3 +/- 8.3 years) with a Hamilton depression rating scale score above 18, who were drug-naive or drug-free for >or=4 weeks, and 49 healthy controls matched for age (+/-2 years) and sex. Subjects were scanned with single photon em...
Major Depressive Disorder (MDD) is a complex and widespread mental illness. Despite decades of dedic...
Background—Several biological abnormalities in major depressive disorder (MDD) persist during episod...
BACKGROUND: Single photon emission tomography (SPET) with the dopamine D2/3 ligand 123I-IBZM gives a...
Several studies have reported low brain serotonin transporter (SERT) binding in individuals with maj...
The serotonergic system may play an important role in the pathophysiology of major depressive disord...
PURPOSE: Apart from binding to the dopamine transporter (DAT), [(123)I]FP-CIT shows moderate affinit...
CONTEXT: The serotonin hypothesis of depression invokes a relative or absolute deficit of serotonin ...
The success of serotonin-selective reuptake inhibitors has lent support to the monoamine theory of m...
The success of serotonin-selective reuptake inhibitors has lent support to the monoamine theory of m...
BACKGROUND: The serotonin transporter (5-HTT) plays a critical role in the regulation of serotonin n...
OBJECTIVE: The serotonin transporter (5-HTT) is a key target for selective serotonin reuptake inhibi...
Abstract Background Results obtained from brain imaging studies indicate that serotonin transporter ...
Context: The biological basis for the development of major depressive disorder (MDD) remains incompl...
Introduction The role of the serotonergic system in Parkinson's disease (PD) depression is unclear. ...
Selective serotonin reuptake inhibitors (SSRIs) modulate serotonergic neurotransmission by blocking ...
Major Depressive Disorder (MDD) is a complex and widespread mental illness. Despite decades of dedic...
Background—Several biological abnormalities in major depressive disorder (MDD) persist during episod...
BACKGROUND: Single photon emission tomography (SPET) with the dopamine D2/3 ligand 123I-IBZM gives a...
Several studies have reported low brain serotonin transporter (SERT) binding in individuals with maj...
The serotonergic system may play an important role in the pathophysiology of major depressive disord...
PURPOSE: Apart from binding to the dopamine transporter (DAT), [(123)I]FP-CIT shows moderate affinit...
CONTEXT: The serotonin hypothesis of depression invokes a relative or absolute deficit of serotonin ...
The success of serotonin-selective reuptake inhibitors has lent support to the monoamine theory of m...
The success of serotonin-selective reuptake inhibitors has lent support to the monoamine theory of m...
BACKGROUND: The serotonin transporter (5-HTT) plays a critical role in the regulation of serotonin n...
OBJECTIVE: The serotonin transporter (5-HTT) is a key target for selective serotonin reuptake inhibi...
Abstract Background Results obtained from brain imaging studies indicate that serotonin transporter ...
Context: The biological basis for the development of major depressive disorder (MDD) remains incompl...
Introduction The role of the serotonergic system in Parkinson's disease (PD) depression is unclear. ...
Selective serotonin reuptake inhibitors (SSRIs) modulate serotonergic neurotransmission by blocking ...
Major Depressive Disorder (MDD) is a complex and widespread mental illness. Despite decades of dedic...
Background—Several biological abnormalities in major depressive disorder (MDD) persist during episod...
BACKGROUND: Single photon emission tomography (SPET) with the dopamine D2/3 ligand 123I-IBZM gives a...